- Cancer Biology & Biomarkers
- Chromatography & Mass Spectrometry
- Contract Research, Clinical Trials and Outsourcing
- Drug Discovery
- Drug Targets
- Flow Cytometry
- Informatics & Lab Automation
- Ingredients, Excipients and Dosages
- Microbiology & RMMs
- NIR, PAT & QbD
- Raman Spectroscopy
- Screening, Assays & High-Content Analysis
- Thermal Processing
ECDC survey shows increasing threat of antibiotic resistance
18 November 2015 • Author: Victoria White
Survey results released by the European Centre for Disease Prevention and Control (ECDC) show that the situation continues to worsen with regard to the spread of carbapenemase producing Enterobacteriaceae (CPE) in the EU, with eight countries reporting an interregional spread and three countries an endemic situation.
This means that in these three countries most hospitals are repeatedly seeing patients that cannot be treated with carbapenems, a last-line antibiotic group. The data comes from the European Survey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) on the spread in Europe’s hospitals of bacteria resistant to carbapenems.
On the other hand, the survey also shows that national capacity for the containment of CPE in the EU is increasing.
Vytenis Andriukaitis, European Commissioner for Health and Food Safety said: “The ECDC results published today show that the threat of antibiotic resistance is increasing day by day. If left unchecked, it has the capacity to turn the clock back on medicine by a hundred years. We are working together with the Member States and our international partners to ensure that we strengthen the prevention and control of antimicrobial resistance across all sectors in a “one-health” approach and to secure the availability of new antimicrobial agents for the future.”
Antibiotic consumption in the hospital sector is still increasing
ECDC also released its latest data on antibiotic resistance (EARS-Net) and consumption (ESAC-Net) in Europe. Resistance continues to rise for most bacteria and antibiotics under surveillance; however, there are some exceptions like meticillin-resistant Staphylococcus aureus (MRSA). For the first time, data show a significant decrease in antibiotic consumption in the community in five European countries: Denmark, Luxembourg, Slovenia, Spain and Sweden. Nevertheless, antibiotic consumption in the hospital sector, overall and for carbapenems, is still increasing.
ECDC Acting Director, Dr Andrea Ammon said: “The further spread of CPE, meaning bacteria resistant to carbapenems, a last-line group of antibiotics, is a cause for major concern in the EU as alternative options for the treatment of infected patients are limited. ECDC is encouraged to see that many EU countries have taken action to combat CPE, with national plans and other measures. However, there is more work to be done at all levels, local, national and European.
“Decreasing antibiotic consumption in 5 countries shows that Europe is moving towards a more prudent use of antibiotics in the community. Prudent antibiotic use in both the community and in hospitals is critical to make sure that we are getting the most out of existing drugs.”
ABB Analytical Measurement ACD/Labs ADInstruments Ltd Advanced Analytical Technologies GmbH Analytik Jena AG Astell Scientific Ltd B&W Tek Bachem AG Bibby Scientific Limited Bio-Rad Laboratories BioNavis Ltd Biopharma Group Black Swan Analysis Limited Butterworth Laboratories Ltd CAPSUGEL NV Charles Ischi AG | Kraemer Elektronik Cherwell Laboratories CI Precision Cobalt Light Systems Coulter Partners CPC Biotech srl Dassault Systèmes BIOVIA DiscoverX Edinburgh Instruments Enterprise System Partners (ESP) Eurofins BioPharma Product Testing EUROGENTEC F.P.S. Food and Pharma Systems Srl GE Analytical Instruments IDBS JEOL Europe Kaiser Optical Systems Inc. L.B. Bohle Maschinen + Verfahren GmbH Lab M Ltd. LabWare Linkam Scientific Instruments Limited Lonza MA Business Metrohm Molins Technologies Multicore Dynamics Ltd Nanosurf New England Biolabs, Inc. Ocean Optics Panasonic Biomedical Sales Europe B.V. Peak Scientific ReAgent Russell Finex Limited Sentronic GmbH Source BioScience Takara Clontech Tornado Spectral Systems Tuttnauer Viavi Solutions, Inc Watson-Marlow Fluid Technology Group Wickham Laboratories Limited WITec GmbH Xylem Analytics YMC Europe GmbH Yusen Logistics